Monoclonal Mouse anti‑Human LHX4 Antibody (clone OTI1C7, Carrier‑free, aa1‑260, IHC, WB) LS‑C792133
Monoclonal Mouse anti‑Human LHX4 Antibody (clone OTI1C7, Carrier‑free, aa1‑260, IHC, WB) LS‑C792133
Antibody:
LHX4 Mouse anti-Human Monoclonal (aa1-260) (Carrier-free) (OTI1C7) Antibody
Format:
Unconjugated, Carrier-free
Overview
Antibody:
LHX4 Mouse anti-Human Monoclonal (aa1-260) (Carrier-free) (OTI1C7) Antibody
Format:
Unconjugated, Carrier-free
Specifications
Description
LHX4 antibody LS-C792133 is an unconjugated mouse monoclonal antibody to human LHX4 (aa1-260). Validated for IHC and WB.
Target
Human LHX4
Synonyms
LHX4 | CPHD4 | Gsh4 | LIM homeobox protein 4 | LIM/homeobox protein Lhx4 | LIM homeobox 4
Reactivity
Human
(tested or 100% immunogen sequence identity)
Clonality
IgG1
Monoclonal
Conjugations
Unconjugated
Purification
Affinity chromatography
Modifications
Carrier-free.
Also available
Unmodified.
Immunogen
Human recombinant protein fragment corresponding to amino acids 1-260 of human LHX4 (NP_203129) produced in E.coli.
Applications
- IHC (1:150)
- Western blot (1:2000)
|
Performing IHC? See our complete line of Immunohistochemistry Reagents including antigen retrieval solutions, blocking agents
ABC Detection Kits and polymers, biotinylated secondary antibodies, substrates and more.
|
Usage
Applications should be user optimized.
Presentation
PBS, pH 7.3, 8% Trehalose
Reconstitution
Reconstitute with PBS pH 7.3. To use this carrier-free antibody for conjugation experiment, we strongly recommend you to perform another round of desalting process.
Storage
Store at -20°C. Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human
Applications:
IHC, IHC - Paraffin, Western blot, ELISA
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 1/10/2025